02493.HK
MABWELL-B
HKSE · Healthcare · Biotechnology · CN
HKD 18.23
−1.99%Margins
Gross margin
74.5%
EBITDA margin
-73.5%
EBIT margin
-98.4%
Net margin
-107.5%
FCF margin
-102.7%
-107.6%
Return on equity
-17.8%
Return on assets
-20.3%
Return on invested capital
0.18x
Asset turnover
-HKD 900.4M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026